Matson
MATX · NYSE
About MATX
- Employees
- 4,170
- Headquarters
- Honolulu, Hawaii
- Listed
- Mar 17, 1980
- Sector
- Industrials
- Industry
- Marine Transportation
- Website
- matson.com
MATX key statistics
- Market cap
- 7.10B
- Price-earnings ratio
- 15.57
- Dividend yield
- 0.63%
- Average volume
- 279.92K
- Volume
- 306.60K
- Open price
- $232.02
- High today
- $240.40
- Low today
- $231.78
- 52 Week high
- $240.87
- 52 Week low
- $92.64
Matson (MATX) at a glance
As of Oct 20, 2026, Matson (MATX) shares are priced at $237.27, giving the company a market cap of 7.10B, a price-to-earnings ratio of 15.57 and a dividend yield of 0.63%.
Today the stock has traded between $231.78 and $240.40. The current price is 2.4% above the day's low and 1.3% below its high.
Volume so far is 306.60K shares, in line with the average of 279.92K shares a day.
Over the past year Matson has ranged from $92.64 to $240.87, and now sits 98% of the way up that range.
Matson met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $4.27 per share against an estimate of $3.87.
The average analyst price target is $267.07, 12.6% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $261.59
- Now
- $237.27
- High
- $281.75
MATX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 15.1% on average.
- Q3 FY24: reported $5.89 per share against an estimate of $4.84
- Q4 FY24: reported $3.80 per share against an estimate of $3.41
- Q1 FY25: reported $2.18 per share against an estimate of $2.17
- Q2 FY25: reported $2.92 per share against an estimate of $2.10
- Q3 FY25: reported $4.24 per share against an estimate of $3.32
- Q4 FY25: reported $4.60 per share against an estimate of $4.56
- Q1 FY26: reported $1.85 per share against an estimate of $1.69
- Q2 FY26: reported $4.27 per share against an estimate of $3.87
MATX news
- Press releasePRNewswire
- Press releasePRNewswire
/C O R R E C T I O N - Matson, Inc./
- Press releasePRNewswire
MATSON CHRISTENS NEXT ALOHA CLASS VESSEL 'MAKUA'
- Avi Kapoor
5 Stock Picks Last Month From Wall Street's Most Accurate Analysts
- Press releasePRNewswire
MATSON, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS AND RAISES FULL YEAR OUTLOOK
- Press releasePRNewswire
MATSON ANNOUNCES PRELIMINARY 2Q26 RESULTS, PROVIDES BUSINESS UPDATE AND ANNOUNCES 2Q26 EARNINGS CALL DATE
- Press releasePRNewswire
MATSON PUBLISHES 2025 SUSTAINABILITY REPORT
- Press releasePRNewswire
MATSON INCREASES QUARTERLY DIVIDEND TO $0.38 PER SHARE
Similar companies
Companies in the same industry as Matson
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.